Check out this article titled: Family Matters: Germline Testing in Thoracic Cancers
https://ascopubs.org/doi/full/10.1200/EDBK_389956
TOMIC-Meso: a randomized phase 2/3 trial of ADI-PEG20 or placebo with pemetrexed and cisplatin in patients with argininosuccinate synthetase 1-deficient non-epithelioid mesothelioma
If you have the time, read this publication: ATOMIC-Meso: a randomized phase 2/3 trial of ADI-PEG20 or placebo with pemetrexed and cisplatin in patients with argininosuccinate synthetase 1-deficient non-epithelioid mesothelioma
Carbon nanotube pathogenicity conforms to a unified theory for mesothelioma causation by elongate materials and fibers
Article titled “Carbon nanotube pathogenicity conforms to a unified theory for
mesothelioma causation by elongate materials and fibers” https://www.sciencedirect.com/science/article/pii/S0013935122019077
Multi-Walled Carbon Nanotube-Induced Gene Expression Biomarkers for Medical and Occupational Surveillance
Article titled “Multi-Walled Carbon Nanotube-Induced Gene Expression Biomarkers for Medical and Occupational Surveillance” https://www.researchgate.net/publication/333464975_Multi-Walled_Carbon_Nanotube-Induced_Gene_Expression_Biomarkers_for_Medical_and_Occupational_Surveillance
Second Primary Cancers in a Population-Based Mesothelioma Registry
New Publication titled “Second Primary Cancers in a Population-Based Mesothelioma Registry” https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10046097/
New pathogenic germline variants identified in mesothelioma
2023 paper titled “New pathogenic germline variants identified in mesothelioma” accepted last week in Lung Cancer by Belcaid (Denmark). https://pubmed.ncbi.nlm.nih.gov/36944283/
Laying the Foundation for a Mesothelioma Patient Registry: Development of Data Collection Tools
Laying the Foundation for a Mesothelioma Patient Registry: Development of Data Collection Tools! Read it here: https://lnkd.in/evedTGgw